The University of Sydney, Children's Hospital Westmead Clinical School, Westmead, Australia.
Institute of Endocrinology and Diabetes and Weight Management Services, The Children's Hospital at Westmead, Westmead, Australia.
Obes Rev. 2019 Sep;20(9):1287-1298. doi: 10.1111/obr.12866. Epub 2019 May 26.
This review aimed to investigate the impact of obesity treatment, with a dietary component, on eating disorder (ED) prevalence, ED risk, and related symptoms in children and adolescents with overweight or obesity. Four databases were searched to identify pediatric obesity treatment interventions, with a dietary component, and validated pre-post intervention assessment of related outcomes. Of 3078 articles screened, 36 met inclusion criteria, with a combined sample of 2589 participants aged 7.8 to 16.9 years. Intervention duration ranged from 1 week to 13 months, with follow-up of 6 months to 6 years from baseline. Prevalence of ED was reported in five studies and was reduced post-intervention. Meta-analyses showed a reduction in bulimic symptoms (eight studies, standardized mean difference [SE], -0.326 [0.09], P < 0.001), emotional eating (six studies, -0.149 [0.06], P = 0.008), binge eating (three studies, -0.588 [0.10], P < 0.001), and drive for thinness (three studies, -0.167 [0.06], P = 0.005) post-intervention. At follow-up, a reduction in ED risk (six studies, -0.313 [0.13], P = 0.012), emotional eating (five studies, -0.259 [0.05], P < 0.001), eating concern (three studies, -0.501 [0.06], P < 0.001), and drive for thinness (two studies, -0.375 [0.07], P < 0.001) was found. Structured and professionally run obesity treatment was associated with reduced ED prevalence, ED risk, and symptoms.
本综述旨在研究包含饮食成分的肥胖治疗对超重或肥胖儿童和青少年进食障碍(ED)患病率、ED 风险和相关症状的影响。我们检索了四个数据库,以确定包含饮食成分的儿科肥胖治疗干预措施,并对相关结果进行了经过验证的干预前后评估。在筛选出的 3078 篇文章中,有 36 篇符合纳入标准,共有 2589 名年龄在 7.8 至 16.9 岁的参与者纳入了最终的分析。干预持续时间从 1 周到 13 个月不等,从基线开始的随访时间为 6 个月至 6 年。五项研究报告了 ED 的患病率,且干预后患病率降低。荟萃分析显示,在八项研究中,贪食症状(标准化均数差 [SE],-0.326 [0.09],P < 0.001)、情绪性进食(六项研究,-0.149 [0.06],P = 0.008)、暴食(三项研究,-0.588 [0.10],P < 0.001)和对苗条的渴望(三项研究,-0.167 [0.06],P = 0.005)在干预后均减少。在随访中,六项研究发现 ED 风险(-0.313 [0.13],P = 0.012)、情绪性进食(五项研究,-0.259 [0.05],P < 0.001)、进食关注(三项研究,-0.501 [0.06],P < 0.001)和对苗条的渴望(两项研究,-0.375 [0.07],P < 0.001)均降低。结构化和专业管理的肥胖治疗与 ED 患病率、ED 风险和症状的降低有关。